Camp4 Therapeutics Corp.(CAMP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CAMP Camp4 Therapeutics Corp.

Post-Mkt 07-23 16:14:20 EDT

3.01

-0.10

-3.22%

盘后3.01

+0.000.00%

16:10 EDT

High3.22	Low2.94	Vol182.18K
Open3.08	D1 Closing3.11	Amplitude9.00%
Mkt Cap156.16M	Tradable Cap82.68M	Total Shares51.88M
T/O547.77K	T/O Rate0.66%	Tradable Shares27.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CAMP","market":"US","secType":"STK","nameCN":"Camp4 Therapeutics Corp.","latestPrice":3.01,"timestamp":1784836800000,"preClose":3.11,"halted":0,"volume":182179,"hourTrading":{"tag":"盘后","latestPrice":3.01,"preClose":3.01,"latestTime":"16:10 EDT","volume":1141,"amount":3434.41,"timestamp":1784837404710,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.032154340836012894,"floatShares":27468000,"shares":51881100,"eps":-2.2425,"marketStatus":"Post-Mkt","change":-0.1,"latestTime":"07-23 16:14:20 EDT","open":3.08,"high":3.22,"low":2.94,"amount":547773.0298613,"amplitude":0.090032,"askPrice":3.15,"askSize":300,"bidPrice":2.75,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.2425,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1784851200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":3.11,"preHourTrading":{"tag":"盘前","latestPrice":3.3,"preClose":3.11,"latestTime":"09:28 EDT","volume":67,"amount":217.5400019,"timestamp":1784813299989,"change":0.19,"changeRate":0.061093,"amplitude":0.032154},"postHourTrading":{"tag":"盘后","latestPrice":3.01,"preClose":3.01,"latestTime":"16:10 EDT","volume":1141,"amount":3434.41,"timestamp":1784837404710,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.804925,"impliedVol":3.7723,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/CAMP/wiki","defaultTab":"wiki","newsList":[{"id":"2652280441","title":"Camp4 Therapeutics Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652280441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652280441?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:05","pubTimestamp":1784318700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA1MZD95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CAMP","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645398888","title":"Positive Report for CAMP4 Therapeutics Corporation (CAMP) from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2645398888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645398888?lang=en_us&edition=fundamental","pubTime":"2026-06-23 20:37","pubTimestamp":1782218235,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Anupam Rama upgraded CAMP4 Therapeutics Corporation to a Buy yesterday and set a price target of $9.00. The company’s shares cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-camp4-therapeutics-corporation-camp-from-j-p-morgan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-camp4-therapeutics-corporation-camp-from-j-p-morgan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0053666078.USD","LU0225283273.USD","IE00BKVL7J92.USD","BK4516","LU1363072403.SGD","LU2111349929.HKD","LU2357305700.SGD","LU0158827781.USD","BK4127","LU0912757837.SGD","LU0882574139.USD","LU0795875169.SGD","LU1720051108.HKD","LU0528227936.USD","IE00BZ1G4Q59.USD","LU1791710582.SGD","BK4534","LU2271345857.HKD","BK4020","LU1064131342.USD","LU0267386448.USD","BK4139","LU1668664300.SGD","BK4581","LU2089283258.USD","LU2133065610.SGD","LU1244550221.USD","LU1074936037.SGD","CAMP","LU2264538146.SGD","LU0006306889.USD","BK4504","LU0234570918.USD","LU0795875086.SGD","LU1732800096.USD","LU0106261372.USD","LU2347655156.SGD","BK4588","LU1988902786.USD","LU0320765646.SGD","LU0106831901.USD","LU2487616109.SGD","LU1720051017.SGD","LU1732799900.SGD","LU2023251221.USD","LU2089284900.SGD","LU1548497426.USD","LU0210528500.USD","LU1162221912.USD","LU1244550494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644066147","title":"Camp4 Therapeutics grants 39,000 inducement stock options at $3.96 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2644066147","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644066147?lang=en_us&edition=fundamental","pubTime":"2026-06-20 04:10","pubTimestamp":1781899838,"startTime":"0","endTime":"0","summary":"Camp4 Therapeutics granted non-qualified stock options covering 39,000 shares to three newly hired employees on June 15, 2026.Options carry a 10-year term with an exercise price of USD 3.96 per share, matching the stock’s closing price on the grant date.Awards vest over four years: 25% after one year, then the balance in 36 equal monthly installments, subject to continued service.Grants were issued under the company’s 2026 Inducement Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief on June 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260619:nNDL4pchPL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAMP","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644669200","title":"Camp4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644669200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644669200?lang=en_us&edition=fundamental","pubTime":"2026-06-20 04:05","pubTimestamp":1781899500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260619:nTUA5P5RF4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAMP","BK4020","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644762446","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2644762446","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644762446?lang=en_us&edition=fundamental","pubTime":"2026-06-17 03:18","pubTimestamp":1781637533,"startTime":"0","endTime":"0","summary":"Healthcare stocks edged lower late Tuesday afternoon, with the NYSE Healthcare Index decreasing 0.2% and the State Street Health Care Select Sector SPDR ETF  easing 0.1%.The iShares Biotechnology ETF  was down 0.%.In corporate news, CAMP4 Therapeutics  shares jumped past 7% after JPMorgan upgraded the stock to overweight from neutral and raised its price target to $9 from $5.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4139","BK4581","IBB","HCSG","BK4137","LU0128526141.USD","LU0029874061.USD","BK4588","LABU","XBI","CAMP","BK4020","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643475900","title":"Discovr Radio to Embed Across All Four Days of CAMP Toronto in First Major Activation with Beatcave","url":"https://stock-news.laohu8.com/highlight/detail?id=2643475900","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643475900?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:00","pubTimestamp":1781607600,"startTime":"0","endTime":"0","summary":"Live demo listening session to approve artists onto the platform in real time New “golden ticket” subscriptions reward breakout performers on the spot Studio takeover and on-site activations give crea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3312415/0/en/Discovr-Radio-to-Embed-Across-All-Four-Days-of-CAMP-Toronto-in-First-Major-Activation-with-Beatcave.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4023","AGIX","BK4139","ARTY","CAMP","AIPO","BK4543","BK4551","AUUD","BK4585","BK4020","AI","AIYY","CHAT","BK4587","BK4528"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643753262","title":"Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2643753262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643753262?lang=en_us&edition=fundamental","pubTime":"2026-06-16 17:40","pubTimestamp":1781602829,"startTime":"0","endTime":"0","summary":"JPMorgan upgraded Camp4 Therapeutics (CAMP) to Overweight from Neutral with a price target of $9, up from $5. The shares are undervalued on the pot...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/camp4-therapeutics-upgraded-to-overweight-from-neutral-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/camp4-therapeutics-upgraded-to-overweight-from-neutral-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","CAMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643773247","title":"U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2643773247","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643773247?lang=en_us&edition=fundamental","pubTime":"2026-06-16 16:11","pubTimestamp":1781597519,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions BancorporationJune 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nL8N42O0EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FITB","XOMX","KRYS","BETR","FCEL","KMX","XOMO","HWM","KMT","XOM","BBIO","AKTS","CFG","XOMZ","CSR","ROKU","BK4159","DT","ZION","KEY","LU0029874061.USD","PLAY","AIT","LU1150488218.USD","BK4147","INSM","EMR","FAST","CCL","EXR","FOXA","AMGN","LEN","HBAN","HPP","IE0002141913.USD","FICO","MSM","ELF","ESAB","CAMP","GPC","BDC","BK4533","COHU","CVLT","DOMO","EFX","KRC","FLUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643133352","title":"CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2643133352","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643133352?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:42","pubTimestamp":1781296936,"startTime":"0","endTime":"0","summary":"CAMP4 Therapeutics Corporation ( ($CAMP) ) just unveiled an announcement. On June 10, 2026, CAMP4 Therapeutics stockholders approved an amendment t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/camp4-shareholders-approve-equity-plan-changes-and-inducement-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/camp4-shareholders-approve-equity-plan-changes-and-inducement-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4215","CAMP","EQR","BK4020","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643188672","title":"Camp4 Therapeutics shareholders approve amendment to 2024 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2643188672","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643188672?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:12","pubTimestamp":1781295144,"startTime":"0","endTime":"0","summary":"Camp4 Therapeutics held its annual shareholder meeting on June 10, 2026.Shareholders backed an amendment to the 2024 Equity Incentive Plan, updating the evergreen share-count formula to include outstanding pre-funded warrants.The board also adopted a 2026 Inducement Plan authorizing up to 500,000 shares for equity awards; no grants were reported.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDLb0BRT0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4020","BK4139","CAMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642426971","title":"CAMP4 Therapeutics Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2642426971","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642426971?lang=en_us&edition=fundamental","pubTime":"2026-06-10 20:45","pubTimestamp":1781095500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CAMP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 10, 2026 08:45 ET (12:45 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4020","BK4007","LENZ","BK4139","CAMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642440265","title":"Chardan Initiates Camp4 Therapeutics at Buy With $6.50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2642440265","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642440265?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:44","pubTimestamp":1781088262,"startTime":"0","endTime":"0","summary":"Camp4 Therapeutics (CAMP) has an average rating of buy and mean price target of $7.79, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CAMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642944609","title":"Camp4 Therapeutics initiated with a Buy at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2642944609","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642944609?lang=en_us&edition=fundamental","pubTime":"2026-06-10 16:20","pubTimestamp":1781079608,"startTime":"0","endTime":"0","summary":"Chardan analyst Keay Nakae initiated coverage of Camp4 Therapeutics (CAMP) with a Buy rating and $6.50 price target The firm cites the potential of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/camp4-therapeutics-initiated-with-a-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/camp4-therapeutics-initiated-with-a-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAMP","BK4139","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642445098","title":"U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2642445098","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642445098?lang=en_us&edition=fundamental","pubTime":"2026-06-10 15:48","pubTimestamp":1781077690,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, OracleJune 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Datadog, Eli Li","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nL4N42I0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETR","ELIS","ANAB","DDOG","LU2237443465.HKD","CPT","NETX","LLYX","FANG","ELTX","LLY","CAVA","ILMN","CAMP","NETG","AOS","ASH","NET","DOGD","DOW","ECL","BELFB","AVB","ASO","CBRL","CARR","EQR","LU1035775433.USD","CLDX","BILL","EMR","DBI","CASY","CECO","HYLN","HON","BWA","BNZI","LU1917777945.USD","CVLT","DVN","ESS","MMM","LLYZ","AMAT","ELIL","HNGE","LLII","IE00BMG7P926.USD","COR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642441742","title":"CAMP4 Therapeutics Corporation (CAMP) Receives a New Rating from Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2642441742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642441742?lang=en_us&edition=fundamental","pubTime":"2026-06-10 13:05","pubTimestamp":1781067917,"startTime":"0","endTime":"0","summary":"CAMP4 Therapeutics Corporation received a Buy rating and a $6.50 price target from Chardan Capital analyst Keay Nakae today. Nakae covers the Healt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/camp4-therapeutics-corporation-camp-receives-a-new-rating-from-chardan-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/camp4-therapeutics-corporation-camp-receives-a-new-rating-from-chardan-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642793412","title":"Camp4 Therapeutics Corp : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $6.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2642793412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642793412?lang=en_us&edition=fundamental","pubTime":"2026-06-10 12:27","pubTimestamp":1781065630,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42I00O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAMP","BK4139","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911104","title":"U.S. big tech holds 85% of Canadian cloud market, report says ahead of AI strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911104","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640911104?lang=en_us&edition=fundamental","pubTime":"2026-06-02 17:10","pubTimestamp":1780391400,"startTime":"0","endTime":"0","summary":"Three big U.S. tech companies control the vast majority of Canada’s publicly-available cloud infrastructure, says a new report released ahead of the government’s national AI strategy, which is expected to include measures targeting AI sovereignty.","market":"sg","thumbnail":"https://www.bnnbloomberg.ca/resizer/v2/TK5OLF4TD73SFMCOXB5L75SMO4.jpg?smart=true&auth=cdf758f05f08e7bff8c2f9ad652625cb82cd3db2fba5fff08d087e2100fdafb1&width=800&height=450","type":0,"news_type":0,"thumbnails":["https://www.bnnbloomberg.ca/resizer/v2/TK5OLF4TD73SFMCOXB5L75SMO4.jpg?smart=true&auth=cdf758f05f08e7bff8c2f9ad652625cb82cd3db2fba5fff08d087e2100fdafb1&width=800&height=450"],"rights":{"source":"bnn_bloomberg_highlight","url":"https://www.bnnbloomberg.ca/business/artificial-intelligence/2026/06/02/us-big-tech-holds-85-of-canadian-cloud-market-report-says-ahead-of-ai-strategy/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/business/artificial-intelligence/2026/06/02/us-big-tech-holds-85-of-canadian-cloud-market-report-says-ahead-of-ai-strategy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["ARTY","AI","BK4588","CAMP","AGIX","BK4587","CHAT","BK4528","MAGS","AIPO","BK4139","BK4551","AIYY","BK4543","BK4020","BK4585","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637354115","title":"Camp4 Therapeutics grants inducement option for 5,000 shares at $4.31 exercise price","url":"https://stock-news.laohu8.com/highlight/detail?id=2637354115","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637354115?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:23","pubTimestamp":1779394998,"startTime":"0","endTime":"0","summary":"Camp4 Therapeutics granted a non-qualified stock option for 5,000 shares to a newly hired employee on May 15, 2026.Exercise price set at $4.31 per share, matching the closing price on the grant date.The option carries a 10-year term with vesting over four years, including 25% after one year, then monthly vesting of the remainder over 36 months, subject to continued service.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL2qNzmT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4020","BK4139","CAMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637467351","title":"Camp4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637467351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637467351?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:05","pubTimestamp":1779393901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUAXF6WT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAMP","BK4139","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635743896","title":"CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635743896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635743896?lang=en_us&edition=fundamental","pubTime":"2026-05-14 21:38","pubTimestamp":1778765894,"startTime":"0","endTime":"0","summary":"The latest announcement is out from CAMP4 Therapeutics Corporation ( ($CAMP) ). On May 14, 2026, CAMP4 Therapeutics reported new preclinical data s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/camp4-highlights-preclinical-progress-of-syngap1-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/camp4-highlights-preclinical-progress-of-syngap1-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4020","BK4097","PRGS","CAMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.camp4tx.com","stockEarnings":[{"period":"1week","weight":-0.2613},{"period":"1month","weight":-0.2595},{"period":"3month","weight":-0.2995},{"period":"6month","weight":-0.2244},{"period":"1year","weight":0.8623},{"period":"ytd","weight":-0.4927}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0041},{"period":"3month","weight":0.055},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.096}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":" ","yearOnYearQuotes":[{"month":1,"riseRate":0.682927,"avgChangeRate":0.082077},{"month":2,"riseRate":0.463415,"avgChangeRate":-0.002283},{"month":3,"riseRate":0.414634,"avgChangeRate":-0.012666},{"month":4,"riseRate":0.475,"avgChangeRate":0.03701},{"month":5,"riseRate":0.55,"avgChangeRate":0.007695},{"month":6,"riseRate":0.390244,"avgChangeRate":-0.040171},{"month":7,"riseRate":0.35,"avgChangeRate":0.010243},{"month":8,"riseRate":0.55,"avgChangeRate":0.035717},{"month":9,"riseRate":0.512195,"avgChangeRate":0.024414},{"month":10,"riseRate":0.45,"avgChangeRate":0.026175},{"month":11,"riseRate":0.5,"avgChangeRate":0.04865},{"month":12,"riseRate":0.375,"avgChangeRate":-0.039343}],"exchange":"NASDAQ","name":"Camp4 Therapeutics Corp.","nameEN":"Camp4 Therapeutics Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Camp4 Therapeutics Corp.(CAMP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Camp4 Therapeutics Corp.(CAMP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Camp4 Therapeutics Corp.,CAMP,Camp4 Therapeutics Corp.股票,Camp4 Therapeutics Corp.股票老虎,Camp4 Therapeutics Corp.股票老虎国际,Camp4 Therapeutics Corp.行情,Camp4 Therapeutics Corp.股票行情,Camp4 Therapeutics Corp.股价,Camp4 Therapeutics Corp.股市,Camp4 Therapeutics Corp.股票价格,Camp4 Therapeutics Corp.股票交易,Camp4 Therapeutics Corp.股票购买,Camp4 Therapeutics Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Camp4 Therapeutics Corp.(CAMP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Camp4 Therapeutics Corp.(CAMP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}